Emilie Rousseau
- Aging top 10%
-
- Gut microbiota and health 2
- Pluripotent Stem Cells Research 1
- CRISPR and Genetic Engineering 1
-
- Peptidase Inhibition and Analysis 3
-
- Calcium signaling and nucleotide metabolism 2
-
- Viral gastroenteritis research and epidemiology 1
-
- Microbial Metabolites in Food Biotechnology 1
-
- Salmonella and Campylobacter epidemiology 1
Emilie Rousseau
9 papers receiving 504 citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Aging 31
- Business and International Management 34
- Molecular Medicine 30
- Endocrinology 30
- Molecular Biology 385
Countries citing papers authored by Emilie Rousseau
This map shows the geographic impact of Emilie Rousseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilie Rousseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilie Rousseau more than expected).
Fields of papers citing papers by Emilie Rousseau
This network shows the impact of papers produced by Emilie Rousseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilie Rousseau. The network helps show where Emilie Rousseau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emilie Rousseau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 33 | |
| 2 | 2020 | 40 | |
| 3 | 2019 | 33 | |
| 4 | CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncationsbreakdown → | 2019 | 310 |
| 5 | 2018 | 3 | |
| 6 | 2018 | 1 | |
| 7 | 2014 | 40 | |
| 8 | [Prevalence of Aeromonas spp. pediatric gastroenteritis]. | 1988 | 2 |
| 9 | 1985 | 50 |
About Emilie Rousseau
Emilie Rousseau is a scholar working on Physiology, Molecular Medicine and Endocrinology, having authored 9 papers that have together received 512 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Gut microbiota and health (2 papers), Calcium signaling and nucleotide metabolism (2 papers), Viral gastroenteritis research and epidemiology (1 paper), Microbial Metabolites in Food Biotechnology (1 paper), Pluripotent Stem Cells Research (1 paper), Salmonella and Campylobacter epidemiology (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Aging (31 citations), Business and International Management (34 citations) and Molecular Medicine (30 citations). Emilie Rousseau has collaborated with scholars based in France, Germany and Austria. Frequent co-authors include Charles Diviès, Hervé Prévost, Veronique Guyonnet‐Dupérat, Béatrice Turcq, Martin Teichmann, Magalie Lalanne, Perrine Pennamen, Cécile Ged, Sandrine Dabernat and Aurélie Bedel. Their work appears in journals such as Nature Communications, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.